Venova Technologies

About

Venova Technologies is a women-led startup developing a novel female birth control device designed to be highly effective, long-acting, and side-effect-free. Our solution is an innovative hormone-free and copper-free contraceptive method with a reduced side effect profile to address global unmet needs in women’s health. Primarily funded by the NIH. Awards → First Place Women Who Empower Award (2021) → First Place Life Sciences Eddie Award (2023) → LabCentral Ignite Golden Ticket Award (2023) → FemHealth Insights First in FemTech Award (2024) → Women's Health Innovation Summit (WHIS) Showcase Award (2024) Programs → NSF I-Corps Program (2019) → IDEA Accelerator (2021-2022) → Massachusetts Innovation Network The Eddies Program (2023) → Pillar VC Frequency Bio Program (2024) → MIT The Engine Blueprint (2024) → Visible Hands Boston (VHBOS) Fellowship (2024) → LabCentral Ignite Fellowship (2024) → The Science Center Capital Readiness Program (2025)

Product

Value proposition

A long-acting, hormone-free, copper-free birth control device that is not intrauterine and aims to be highly effective and side-effect-free.

Founders

• Eric Lee — Co-Founder
• Emily Man — Co-Founder and CEO
• Liz Earley — Co-Founder, COO and CFO
• Val Martinuzzi — Co-Founder

Products

Key features

Technologies

Awards

Investors

News

• Venova Technologies Awarded $2.23M SBIR Phase II Grant From NIH For Novel Contraceptive Device · 2025-07-25T00:00:00.000Z
• Venova Technologies Awarded $2.23M SBIR Phase II Grant From NIH For Novel Contraceptive Device - BioSpace · 2025-07-28T07:00:13.000Z
• Venova Technologies Awarded $2.23M SBIR Phase II Grant From NIH For Novel Contraceptive Device · 2025-07-25T12:00:00.000Z
• Venova Technologies Awarded $2.23M SBIR Phase II Grant From NIH For Novel Contraceptive Device - intelligence360 · 2025-08-06T17:00:00.000Z
• Venova Medical Announces $30 Million Series B Financing and Appointment of New Board Member · 2024-09-04T12:00:56.000Z
• Venova Medical Receives FDA IDE Approval for the VENOS-3 Pivotal Study of the Velocity® Percutaneous AVF System - Venova Medical · 2025-08-21T12:02:48.000Z

Browse similar startups

Related startups

• Vitalic Health — Boston, MA
• Xeomics — Boston, MA
• Xtory — Boston, MA
• 3Daughters — Mansfield, MA
• Acie® Inc. — Bedford, MA
• ActoKine Therapeutics — Newton, MA
• Veridata Health — Houston, TX
• VERSA CARDIO — Corona, CA
• VERY | Virtual Eating Recovery for You — Denver, CA
• Verzi — Salt Lake City, UT
• Veterinary Oncology Partners — Louisville, KY
• VETTED Dermlab — Dallas, TX